Alan P. Lyss, MD

All articles by Alan P. Lyss, MD

Alan P. Lyss, MD

October 8, 2021

Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.

Alan P. Lyss, MD

August 5, 2021

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.

Alan P. Lyss, MD

July 30, 2021

Dr Alan Lyss reviews studies of KRAS G12C mutations in metastatic colorectal cancer.

Alan P. Lyss, MD

July 12, 2021

Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.

Next post in Breast Cancer